In this potent tumor control model, naïve Trp1 T cells first differentiate into TCF1+Ly108+ stem-like cells, which subsequently give rise to TCF1–CXCR6+ Th1-like effector cells. The gene discussed is TYRP1; the disease is neoplasm.